Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002063837-25-000002
Filing Date
2025-05-12
Accepted
2025-05-12 06:49:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4738
  Complete submission text file 0002063837-25-000002.txt   6320
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Subject) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-85411 | Film No.: 25932519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7852, AL BATINAH 2650, AL WOROUD DIST. RIYADH RIYADH Saudi Arabia 12253
Business Address
SHAIBATALHAMD AYMEN ABDALKADER (Filed by) CIK: 0002063837 (see all company filings)

Type: SCHEDULE 13G/A